Fanconi anemia deficiency stimulates HPV-associated hyperplastic growth in organotypic epithelial raft culture

Oncogene

Volumn 28, Issue 5, 2009, Pages 674-685

  Hoskins, E E ^a   Morris, T A ^a   Higginbotham, J M ^a   Spardy, N ^b   Cha, E ^b   Kelly, P ^c   Williams, D A ^d   Wikenheiser Brokamp, K A ^a   Duensing, S ^b   Wells, S I ^a,e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Fanconi anemia; Human papillomavirus; Keratinocyte; Organotypic raft culture

Indexed keywords

FANCONI ANEMIA GROUP A PROTEIN; KI 67 ANTIGEN; MITOMYCIN; PROTEIN E6; PROTEIN E7;

APOPTOSIS; ARTICLE; CANCER RISK; CELL AGING; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EPITHELIUM CELL; EPITHELIUM HYPERPLASIA; FANCONI ANEMIA; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; KERATINOCYTE; MONOLAYER CULTURE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; DNA DAMAGE; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; GENETIC COMPLEMENTATION TEST; GENETIC PREDISPOSITION TO DISEASE; HUMAN PAPILLOMAVIRUS 18; HUMANS; KERATINOCYTES; MITOMYCIN; ONCOGENE PROTEINS, VIRAL; ORGAN CULTURE TECHNIQUES; SKIN NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 59649099099     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.416     Document Type: Article

References (41)

1. Alter BP. (2002). Radiosensitivity in Fanconi's anemia patients. Radiother Oncol 62: 345-347.
2. Alter BP. (2003). Cancer in Fanconi anemia, 1927-2001. Cancer 97: 425-440.
3. Bagby GC, Alter BP. (2006). Fanconi anemia. Semin Hematol 43: 147-156.
4. Bremer M, Schindler D, Gross M, Dork T, Morlot S, Karstens JH. (2003). Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy. Strahlenther Onkol 179: 748-753.
5. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K. (2005). The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet 37: 953-957.
6. Chandra S, Levran O, Jurickova I, Maas C, Kapur R, Schindler D et al. (2005). A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Mol Ther 12: 976-984.
7. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
8. Dorsman JC, Levitus M, Rockx D, Rooimans MA, Oostra AB, Haitjema A et al. (2007). Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol 29: 211-218.
9. Duensing S, Munger K. (2004). Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109: 157-162.
10. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J et al. (2001). Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7: 249-262.
11. Guardiola P, Socie G, Li X, Ribaud P, Devergie A, Esperou H et al. (2004). Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome. Blood 103: 73-77.
12. Hanenberg H, Batish SD, Pollok KE, Vieten L, Verlander PC, Leurs C et al. (2002). Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol 30: 410-420.
13. Hoskins EE, Gunawardena RW, Habash KB, Wise-Draper TM, Jansen M, Knudsen ES et al. (2008). Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway. Oncogene 27: 4798-4808.
14. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C et al. (2002). Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297: 606-609.
15. Huyen Y, Zgheib O, Ditullio Jr RA, Gorgoulis VG, Zacharatos P, Petty TJ et al. (2004). Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432: 406-411.
16. Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG et al. (2003a). High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 129: 106-112.
17. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF et al. (2003b). A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101: 1249-1256.
18. Kutler DI, Wreesmann VB, Goberdhan A, Ben-Porat L, Satagopan J, Ngai I et al. (2003c). Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 95: 1718-1721.
19. Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW et al. (2005). The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 37: 934-935.
20. Longworth MS, Laimins LA. (2004). Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68: 362-372.
21. Marcou Y, D'Andrea A, Jeggo PA, Plowman PN. (2001). Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother Oncol 60: 75-79.
22. Mathew CG. (2006). Fanconi anaemia genes and susceptibility to cancer. Oncogene 25: 5875-5884.
23. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ et al. (2003a). A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 35: 165-170.
24. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, Bier P et al. (2005). A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 37: 958-963.
25. Meetei AR, Sechi S, Wallisch M, Yang D, Young MK, Joenje H et al. (2003b). A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol 23: 3417-3426.
26. Montes de Oca R, Andreassen PR, Margossian SP, Gregory RC, Taniguchi T, Wang X et al. (2005). Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood 105: 1003-1009.
27. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF. (2005). Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J Virol 79: 13150-13165.
28. Niedernhofer LJ, Lalai AS, Hoeijmakers JH. (2005). Fanconi anemia (cross)linked to DNA repair. Cell 123: 1191-1198.
29. Pagano G, Degan P, d'Ischia M, Kelly FJ, Nobili B, Pallardo FV et al. (2005). Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype. Eur J Haematol 75: 93-100.
30. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A et al. (2007). PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39: 165-167.
31. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R et al. (2006). Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39: 162-164.
32. Schambach A, Wodrich H, Hildinger M, Bohne J, Krausslich HG, Baum C. (2000). Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther 2: 435-445.
33. Sims AE, Spiteri E, Sims III RJ, Arita AG, Lach FP, Landers T et al. (2007). FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol 14: 564-567.
34. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald III ER, Hurov KE, Luo J et al. (2007). Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129: 289-301.
35. Spardy N, Duensing A, Charles D, Haines N, Nakahara T, Lambert PF et al. (2007). The human papillomavirus type 16 E7 oncoprotein activates the Fanconi Anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. J Virol 81: 13265-13270.
36. Tamary H, Alter BP. (2007). Current diagnosis of inherited bone marrow failure syndromes. Pediatr Hematol Oncol 24: 87-99.
37. Taniguchi T, D'Andrea AD. (2006). Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107: 4223-4233.
38. Timmers C, Taniguchi T, Hejna J, Reifsteck C, Lucas L, Bruun D et al. (2001). Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 7: 241-248.
39. van Zeeburg HJ, Snijders PJ, Joenje H, Brakenhoff RH. (2004). Re: Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst 96: 968; author reply 968-9.
40. van Zeeburg HJ, Snijders PJ, Pals G, Hermsen MA, Rooimans MA, Bagby G et al. (2005). Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. Cancer Res 65: 1271-1276.
41. Wang W. (2007). Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8: 735-748.